Grace Therapeutics, Inc. · NASDAQ:GRCE

Kohli Prashant bought 100,000 Grace Therapeutics, Inc. shares (Form 4)

Traded Sep 9, 2026 · Filed Sep 10, 2026

On Sep 9, 2026, Kohli Prashant (Director, Chief Executive Officer) bought 100,000 Grace Therapeutics, Inc. shares at US$2.14 for US$214K, leaving 121,357 shares. Filed Sep 10, 2026 (Form 4).

Bought
100,000 shares
Price
US$2.14
Value
US$214K
Holding after
121,357 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 9, 2026Common StockBuy100,000US$2.14121,357Direct

Source

View original at SEC

Related